Discussion
The association between thyroid carcinoma and phaeochromocytoma was emphasised by Sipple."
This familial association was defined as part of a syndrome of multiple endocrine neoplasia type 2 (MEN-2),14 including medullary thyroid and adrenal tumours, described by Sipple, and primary hyperparathyroidism. Later these patients were identified as having MEN-2a' if suffering from medullary thyroid carcinoma (l00o% of cases), phaeochromocytoma (50 %), and hyperparathyroidism (50 %), or as having MEN-2b1 or MEN-315 if suffering from medullary thyroid carcinoma (100 %), phaeochromocytoma (500%), hyperparathyroidism (rare), marfanoid habitus (100%), intestinal ganglioneuromatosis (l000%), and mucosal neuromas (100%).
In the family studied by us, medullary thyroid carcinoma was present in all but one member. There was a manifest phaeochromocytoma in case 6 The finding of a typical deletion or chromosomal instability in MEN-2 could be of value in preclinical and antenatal diagnosis of the syndrome. Today, a growing body of evidence suggests that the locus for MEN-2 is probably on the short arm of chromosome 20. Our negative results as regards the 20p deletion and chromosomal instability do not contradict previous cytogenetic evidence, as the deletion could be so small that even high resolution banding might have failed to detect it.
Another hypothesis is that the gene could be present but abnormal and functionally equivalent to a deleted one. In Wilms's tumour and retinoblastoma the typical deletion is not always present.
